Abstract
To evaluate the osseointegration enhancement, a consecutive randomized series of 50 on a total of 483 cementless titanium prostheses were prospectically studied. The features of the stem were the following: tapered, straight, low-profile neck, metaphyseal and hystmic fit, proximal 1/3 hydroxyapatite coated (HA) and titanium porous coated (PC). The acetabular component was hemispherical, titanium porous coated. A zircornia or Co/Cr head (28mm) was used. Female were 53% and average age 65. The general diagnosis was ostheoarthritis, congenital hip dysplasia, fracture, aseptic loosening, osteonecrosis, previous femoral osteotomy, previous pelvic osteotomy. Clinical objective assessment was based on the HHS. A patient oriented evaluation (Womac and SF12) was obtained. Radiological assessment was based on the Engh’s method. The general and prospectical group results have been evaluated.
In all the groups the HHS, Womac and SF12 questionnaires showed a statistically significant improvement in quality of life. Consistent evidence of proximal bone ingrowth were present in 100 % (HA) and 96 % (PC), stable proximal fibrous ingrowth in 4 % (PC). Cortical hypertrophy (50 % zone 3–5), stress shielding (56 % zone 1) and pedestal ( one case) were assessed. Nor osteolysis neither subsidence were identified. No significant general complications such as infections or periprosthetic fractures were observed. The use of HA seems to improve the mechanism of osseointegration and earlier clinical outcomes, even if this difference is not significant. Patient oriented evaluation and radiographic assessments confirmed the reliability of this cementless prosthesis. Less osteolysis could be predicted in the future, according to the reported results of other authors in the HA coated stems.
The abstracts were prepared by Nico Verdonschot. Correspondence should be addressed to him at Orthopaedic Research Laboratory, University Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
